Back to News
Market Impact: 0.45

Buy or Sell MetLife Stock Ahead of Earnings?

METSPYMDYIWM
Corporate EarningsAnalyst EstimatesCompany FundamentalsMarket Technicals & FlowsInvestor Sentiment & Positioning
Buy or Sell MetLife Stock Ahead of Earnings?

MetLife (MET) is scheduled to announce Q2 2025 earnings on August 6, with consensus estimates projecting a slight year-over-year decline in EPS to $2.16 and revenue to $18.50 billion, influenced by factors such as foreign currency impacts and recurring interest margins. Historically, MetLife's stock has shown a low probability of positive one-day post-earnings returns, occurring only 40% of the time over the past five years (33% over three years), with median positive moves of 2.2% and median negative moves of -1.8%, indicating a challenging historical pattern for immediate upside following announcements.

Analysis

MetLife is approaching its August 6, 2025, earnings release with consensus estimates pointing to a modest year-over-year decline, with earnings per share expected at $2.16 and revenues at approximately $18.50 billion. The company's performance in the previous quarter was characterized by a push-and-pull between positive factors, including increased life underwriting margins and volume growth, and significant headwinds from adverse foreign currency movements and lower recurring interest margins. These same dynamics, particularly the impact of a weak U.S. dollar, are anticipated to influence the upcoming Q2 results. Historical trading data reveals a challenging setup for the stock's immediate post-earnings reaction. Over the past five years, MetLife's stock has registered a positive one-day return on only 40% of its earnings announcements, a probability that decreases to 33% when examining the more recent three-year period. The magnitude of these moves has been relatively contained, with a median positive return of 2.2% and a median negative return of -1.8%, suggesting that while negative reactions are more frequent, they have not been disproportionately severe compared to positive ones.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo